Clorox (NYSE:CLX) Price Target Cut to $151.00 by Analysts at Jefferies Financial Group

Clorox (NYSE:CLX) had its target price reduced by Jefferies Financial Group from $152.00 to $151.00 in a research report sent to investors on Wednesday morning,MarketScreener reports. They currently have a buy rating on the stock.

CLX has been the subject of several other research reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a research note on Friday, January 9th. Bank of America decreased their price target on Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft cut their price objective on Clorox from $114.00 to $112.00 and set a “hold” rating on the stock in a research report on Wednesday. Evercore ISI decreased their target price on Clorox from $132.00 to $115.00 and set an “underperform” rating for the company in a research report on Wednesday. Finally, Wall Street Zen cut shares of Clorox from a “hold” rating to a “sell” rating in a report on Saturday, January 24th. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat, Clorox presently has a consensus rating of “Reduce” and an average target price of $117.00.

Clorox Stock Up 2.3%

Shares of CLX opened at $117.68 on Wednesday. The company has a quick ratio of 0.50, a current ratio of 0.76 and a debt-to-equity ratio of 18.01. The business has a fifty day moving average of $105.39 and a 200 day moving average of $113.99. The company has a market cap of $14.35 billion, a PE ratio of 19.23, a P/E/G ratio of 0.57 and a beta of 0.59. Clorox has a 52-week low of $96.66 and a 52-week high of $159.04.

Clorox (NYSE:CLX) last announced its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing the consensus estimate of $1.43 by ($0.04). The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 11.17% and a return on equity of 299.67%. The company’s revenue was down .8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.55 EPS. On average, sell-side analysts expect that Clorox will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be paid a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a yield of 4.2%. Clorox’s dividend payout ratio is 77.86%.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber bought 4,000 shares of the business’s stock in a transaction on Friday, November 21st. The shares were acquired at an average price of $104.13 per share, with a total value of $416,520.00. Following the transaction, the director owned 13,000 shares of the company’s stock, valued at approximately $1,353,690. This trade represents a 44.44% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.63% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Clorox

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Invesco Ltd. raised its position in shares of Clorox by 138.3% in the 2nd quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock worth $389,648,000 after acquiring an additional 1,883,465 shares in the last quarter. Norges Bank purchased a new position in Clorox in the second quarter valued at about $190,429,000. Van ECK Associates Corp raised its holdings in Clorox by 93.9% in the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after purchasing an additional 1,312,471 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its position in shares of Clorox by 218.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock valued at $149,983,000 after buying an additional 856,873 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC bought a new stake in shares of Clorox in the 2nd quarter valued at about $71,856,000. 78.53% of the stock is currently owned by institutional investors.

Key Stories Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Revenue slightly beat consensus — Q2 revenue came in at about $1.67B, a small beat versus Street estimates, which helps offset some concerns about profitability. Q2 Results Press Release
• Positive Sentiment: Some analysts still see significant upside — Jefferies retains a “buy” rating with a $151 target, signaling that at least part of Wall Street believes longer-term upside remains. Jefferies PT Article
• Neutral Sentiment: Management will present at the CAGNY conference on Feb. 19 — provides an opportunity for management to address questions about margin recovery, inventory and integration progress (potentially market-moving if new color is provided). CAGNY Presentation Notice
• Neutral Sentiment: Mixed small analyst adjustments — JPMorgan nudged its target slightly higher to $117 (neutral), signaling little change in near-term consensus. JPMorgan PT Article
• Negative Sentiment: EPS missed expectations and declined year‑over‑year — adjusted EPS of $1.39 missed consensus (~$1.43) and is down from a year ago, which pressured sentiment. Reuters Earnings Coverage
• Negative Sentiment: Margin headwinds persist — management cited higher costs, ERP/integration pressures and an inventory reset that could squeeze near‑term profits; several outlets flagged margin pressure and a profit squeeze outlook for 2026. Benzinga Profit Squeeze
• Negative Sentiment: Analyst downgrades/price‑target cuts on balance — Evercore cut its PT to $115 (underperform) and Deutsche Bank trimmed its PT to $112 (hold), adding downside risk near current levels. Evercore PT Article Deutsche Bank PT Article

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.